Answers are grounded in this paper and cite their sources.
Among 40 opioid addicts treated as outpatients with sublingual buprenorphine (2-8 mg daily) for a month, depressive symptoms significantly decreased in the 19 who were depressed at intake to treatment.
No takes yet. Share an insight, caveat, or question.
Kosten et al. (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: